Follow-on protein products: scientific issues, developments and challenges
- 31 December 2009
- journal article
- review article
- Published by Elsevier BV in Trends in Biotechnology
- Vol. 27 (12), 698-705
- https://doi.org/10.1016/j.tibtech.2009.09.004
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Regulatory aspects of biosimilars in EuropeTrends in Biotechnology, 2009
- Biochemical Assessment of Erythropoietin Products From Asia Versus US Epoetin alfa Manufactured by AmgenJournal of Pharmaceutical Sciences, 2009
- Toward biosimilar monoclonal antibodiesNature Biotechnology, 2008
- FDA Critical Path Initiatives: Opportunities for Generic Drug DevelopmentThe AAPS Journal, 2008
- Immunogenicity of therapeutic proteins. Part 3: Impact of manufacturing changesBiotechnology Advances, 2007
- Immunogenicity of therapeutic proteins. Part 2: Impact of container closuresBiotechnology Advances, 2007
- Immunogenicity of therapeutic proteins. Part 1: Impact of product handlingBiotechnology Advances, 2007
- Clinical validation of the “in silico” prediction of immunogenicity of a human recombinant therapeutic proteinClinical Immunology, 2007
- A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugsNature Biotechnology, 2007
- The Drug Development Crisis: Efficiency and SafetyAnnual Review of Medicine, 2007